Treatment of Cocaine Dependence With Lisdexamfetamine
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This protocol is a 2-group double-blind placebo-controlled outpatient study investigating
lisdexamfetamine for treatment of cocaine dependence. The investigators plan to enroll 100
subjects in a 14-week trial. The primary objectives will determine changes in cocaine use and
secondary objectives will be cocaine craving and impulsivity.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute